Background: The side effects of antiretroviral drugs and the chronic inflammation induced by human immunodeficiency virus (HIV) infection contribute to the development of atherosclerotic arterial remodeling in people living with HIV (PLWH).
Objectives: To determine the frequency and factors associated with arterial remodeling in PLWH treated at the university hospital of Parakou.
Methods: It was a cross-sectional, descriptive, and analytic study.